• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Calumet Inc.

    6/16/25 9:16:04 AM ET
    $CLMT
    Integrated oil Companies
    Energy
    Get the next $CLMT alert in real time by email
    8-K
    Calumet, Inc. /DE false 0002013745 0002013745 2025-06-10 2025-06-10
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d)

    of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 10, 2025

     

     

    CALUMET, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-42172   36-5098520

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

    1060 N. Capital Avenue

    Suite 6-401

    Indianapolis, Indiana 46204

    (Address of principal executive offices) (Zip Code)

    Registrant’s telephone number, including area code (317) 328-5660

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities Registered Pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, par value $0.01 per share   CLMT   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.07

    Submission of Matters to a Vote of Security Holders.

    On June 10, 2025, Calumet, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”). At the 2025 Annual Meeting, the Company’s stockholders voted on four proposals as described below.

    Proposal No. 1 - Election of Class I Directors

    The Company’s stockholders elected the four Class I director nominees listed below as directors of the Company, each to serve until the Company’s 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified. The voting results were as follows:

     

    Nominees

       For      Withhold      Broker Non-Votes  

    John (“Jack”) G. Boss

         41,616,233        391,687        25,991,156  

    Stephen P. Mawer

         41,505,100        502,820        25,991,156  

    Karen Narwold

         41,611,291        396,629        25,991,156  

    Julio Quintana

         41,615,602        392,318        25,991,156  

    Proposal No. 2 - Advisory Vote to Approve Executive Compensation

    The Company’s stockholders approved, on a non-binding, advisory basis, the Company’s executive compensation. The voting results were as follows:

     

    For:

         40,897,636  

    Against:

         851,240  

    Abstain:

         259,044  

    Broker Non-Votes:

         25,991,156  

    Proposal No. 3 - Advisory Vote on the Frequency of the Executive Compensation Vote

    The Company’s stockholders voted on a non-binding, advisory basis on the frequency of future votes on executive compensation. The voting results were as follows:

     

    1 Year:

         41,196,941  

    2 Years:

         119,286  

    3 Years:

         510,710  

    Abstain:

         180,983  

    Broker Non-Votes:

         25,991,156  

    In light of these voting results, the Company plans to hold future advisory votes on executive compensation annually until the next required vote on the frequency of such advisory votes, or until the Board of Directors of the Company otherwise determines that a different frequency is in the best interests of the Company and its stockholders.

    Proposal No. 4 - Ratification of the Selection of Independent Registered Public Accounting Firm

    The Company’s stockholders ratified the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025. The voting results were as follows:

     

    For:

         67,570,344  

    Against:

         193,850  

    Abstain:

         234,882  


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        CALUMET, INC.
    Date: June 16, 2025     By:  

    /s/ David Lunin

        Name:   David Lunin
        Title:   Executive Vice President and Chief Financial Officer
    Get the next $CLMT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLMT

    DatePrice TargetRatingAnalyst
    5/13/2025$15.00Buy
    BofA Securities
    3/17/2025$15.00 → $12.00Sell → Neutral
    UBS
    3/4/2025$26.00 → $16.00Buy → Hold
    TD Cowen
    2/4/2025$20.50 → $15.00Neutral → Sell
    UBS
    11/11/2024$27.00 → $26.00Buy
    TD Cowen
    10/17/2024$22.00 → $27.00Buy
    TD Cowen
    8/12/2024$20.00 → $18.00Buy
    TD Cowen
    8/18/2022$14.00 → $23.00Neutral → Buy
    Goldman
    More analyst ratings